Nextel Medical Corp. (OTCPK: MAJI)
Health Care · Biotechnology · US
$0.01
-19.54% today · -92.7% 1Y
Nextel Medical Corp. (OTCPK: MAJI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $594.90K and employs 1 people.
Over the last twelve months the share price has lost 92.7%, trading between 0.00 and 0.21.
Tweenvest scores Nextel Medical Corp. across four factors: quality 5/100. Its strongest factor is quality.
MAJI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $594.90K
- Revenue (TTM)
- $-12.83K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -4.72
- 52-week high
- $0.21
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 84.99M
- Employees
- 1
- Next earnings
- —
About Nextel Medical Corp.
Marijuana, Inc. operates as a shell company seeking to merge with another entity with experienced management and opportunities for growth. The company was founded on April 28, 2010 and is headquartered in Estero, FL.
- ISIN
- US36257K2087
- Founded
- 2010
- Listed since
- Feb 9, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €884.60 | -1.93% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.